SCHEMBL4894249

SCHEMBL4894249

Fc1ccc(-c2ccc(Nc3cccc(-c4ccccn4)n3)nc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
TP53 P04637 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
KDM4E B2RXH2 2/20 0.44
LMNA P02545 2/20 0.44
ALOX15 P16050 2/20 0.44
HTT P42858 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ALPL P05186 2/20 0.44
HSP90AA1 P07900 1/20 0.44
ALPI P09923 1/20 0.44
ALPG P10696 1/20 0.44
MAPK1 P28482 1/20 0.44
CCR1 P32246 1/20 0.44
CCR5 P51681 1/20 0.44
CCR8 P51685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895714 0.91 TP53 (0.47) NPC1RAB9AKMT2AMEN1TP53
SCHEMBL4905155 0.90 GRM5 (0.47) NPC1RAB9AKMT2AMEN1TP53
Hydrochloric Acid SCHEMBL4901670 0.88 TP53 (0.47) NPC1RAB9AKMT2AMEN1TP53
SCHEMBL4896808 0.85 TP53 (0.41) NPC1RAB9AKMT2AMEN1TP53
SCHEMBL4902923 0.81 SQOR (0.44) NPC1RAB9AKMT2AMEN1TP53
SCHEMBL4900760 0.80 KARS1 (0.40) NPC1RAB9AKMT2AMEN1TP53
SCHEMBL20919383 0.80 KDM4E (0.68) NPC1RAB9AKMT2AMEN1TP53
SCHEMBL3139492 0.79 GRM5 (0.44) TGFBR1SLC2A1GRM5GPR55
SCHEMBL4899168 0.79 KARS1 (0.43) NPC1RAB9ATP53SMN1; SMN2TDP1
Hydrochloric Acid SCHEMBL3128874 0.78 GRM5 (0.44) TGFBR1SLC2A1GRM5GPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 NPC1 1509/4885RAB9A 3132/4885KMT2A 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.